e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Cystic fibrosis: basic science to clinical context
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Genotype and progressive lung damage in adult cystic fibrosis patients
F. A. Mata, J. De Gracia, A. Alvarez, D. de la Rosa, M. Culebras (Barcelona, Spain)
Source:
Annual Congress 2003 - Cystic fibrosis: basic science to clinical context
Session:
Cystic fibrosis: basic science to clinical context
Session type:
Thematic Poster Session
Number:
3144
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. A. Mata, J. De Gracia, A. Alvarez, D. de la Rosa, M. Culebras (Barcelona, Spain). Genotype and progressive lung damage in adult cystic fibrosis patients. Eur Respir J 2003; 22: Suppl. 45, 3144
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Microcirculation alterations in adult patients with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 262s
Year: 2006
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Early cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 77-87
Year: 2014
Lung function in children with cystic fibrosis liver disease
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
Factors affecting lung function in adult cystic fibrosis patients after lung transplantation.
Source: International Congress 2018 – Evolving approaches to differential diagnosis
Year: 2018
Bacterial infection and lung function in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 615s
Year: 2005
The ageing cystic fibrosis patient
Source: International Congress 2018 – PG18 Cystic fibrosis: management in adult patients
Year: 2018
Early determinants of lung disease in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2019; 83: 158-172
Year: 2019
Factors affecting progression of lung disease among patients with cystic fibrosis
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
Relations between the sinonasal development and the lung disease in cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 103s
Year: 2005
How much genotype influences cystic fibrosis associated liver disease?
Source: Eur Respir J 2006; 28: Suppl. 50, 717s
Year: 2006
Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 32: 170-174
Year: 2008
Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease
Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020
Year: 2021
Prevalence of acute liver dysfunction and chronic liver disease in an Irish adult cystic fibrosis population
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010
Pathophysiology of cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 1-13
Year: 2014
Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 528s
Year: 2002
Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Prevalence of renal impairment in an adult cystic fibrosis (CF) centre
Source: Eur Respir J 2005; 26: Suppl. 49, 622s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept